Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178900 | SCV000231076 | uncertain significance | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311030 | SCV000320434 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-01-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001421490 | SCV001624014 | likely benign | FG syndrome 1 | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178900 | SCV001830898 | benign | not provided | 2021-05-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985289 | SCV004757592 | likely benign | MED12-related disorder | 2022-08-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |